The EVP GLOBAL SALES, MKTG & STGY of Merit Medical Systems is Exercising Options


Yesterday it was reported that the EVP GLOBAL SALES, MKTG & STGY of Merit Medical Systems (MMSI), Justin Lampropoulos, exercised options to sell 8,000 MMSI shares at $13.14 a share, for a total transaction value of $486.9K.

Following Justin Lampropoulos’ last MMSI Sell transaction on November 20, 2018, the stock climbed by 2.1%.

See today’s analyst top recommended stocks >>

Based on Merit Medical Systems’ latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $238 million and quarterly net profit of $6.2 million. In comparison, last year the company earned revenue of $203 million and had a net profit of $5.27 million. MMSI’s market cap is $3.36B and the company has a P/E ratio of 77.74. Currently, Merit Medical Systems has an average volume of 541.3K.

One of the top 25 analysts, according to TipRanks.com, recently recommended Buy MMSI with a $75 price target. Based on 4 analyst ratings, the analyst consensus is Strong Buy with an average price target of $70.00, reflecting a 14.9% upside.

The insider sentiment on Merit Medical Systems has been negative according to 26 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.

Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Merit Medical Systems, Inc. engages in the manufacture and market of proprietary disposable medical devices. It operates through Cardiovascular and Endoscopy segments. The Cardiovascular segment consists of peripheral intervention, cardiac intervention, interventional oncology and spine, and cardiovascular and critical care product groups.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts